Mgenplus Co. Ltd. Cash Flow Conversion Efficiency

Latest as of June 2026: -0.049x

Mgenplus Co. Ltd. cash flow conversion efficiency. Based on the latest financial reports, Mgenplus Co. Ltd. (032790) has a cash flow conversion efficiency ratio of -0.049x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.35 Billion ≈ $-912.17K USD) by net assets (₩27.60 Billion ≈ $18.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Mgenplus Co. Ltd. (2007–2025)

Cash flow conversion efficiency of Mgenplus Co. Ltd. from 2007 to 2025. This chart illustrates how Mgenplus Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Mgenplus Co. Ltd. for real-time trading data and today's change.

Mgenplus Co. Ltd. Cash Flow Conversion Ratio Explained

Mgenplus Co. Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Mgenplus Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mgenplus Co. Ltd. ranked by their cash flow conversion efficiency. Also see Mgenplus Co. Ltd. market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Diagnos Laboratorium Utama PT Tbk JK:DGNS	0.008x
Bio-View Ltd TA:BIOV	0.069x
Mostostal Warszawa S.A. WAR:MSW	1.170x
Perpetuals.com Ltd NASDAQ:PDC	-0.341x
Bankers Investment Trust LSE:BNKR	0.029x
JPEL Private Equity Ltd LSE:JPEL	0.023x
Hamama TA:HMAM	0.187x
TMD Energy Limited NYSE MKT:TMDE	N/A

Annual Cash Flow Conversion Efficiency for Mgenplus Co. Ltd. (2007–2025)

The table below shows the annual cash flow conversion efficiency of Mgenplus Co. Ltd. from 2007 to 2025. Review 032790 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩33.69 Billion ≈ $22.83 Million	₩-2.78 Billion ≈ $-1.89 Million	-0.083x	+38.99%
2024-12-31	₩44.12 Billion ≈ $29.90 Million	₩-5.98 Billion ≈ $-4.05 Million	-0.135x	-141.94%
2023-12-31	₩36.99 Billion ≈ $25.07 Million	₩-2.07 Billion ≈ $-1.40 Million	-0.056x	-308.67%
2022-12-31	₩46.48 Billion ≈ $31.50 Million	₩1.25 Billion ≈ $845.30K	0.027x	+119.77%
2018-12-31	₩18.38 Billion ≈ $12.46 Million	₩-2.49 Billion ≈ $-1.69 Million	-0.136x	+51.90%
2017-12-31	₩22.54 Billion ≈ $15.27 Million	₩-6.36 Billion ≈ $-4.31 Million	-0.282x	-90.52%
2016-12-31	₩11.48 Billion ≈ $7.78 Million	₩-1.70 Billion ≈ $-1.15 Million	-0.148x	+61.17%
2015-12-31	₩8.59 Billion ≈ $5.82 Million	₩-3.28 Billion ≈ $-2.22 Million	-0.381x	-415.25%
2014-12-31	₩10.14 Billion ≈ $6.87 Million	₩1.23 Billion ≈ $831.40K	0.121x	+37.31%
2013-12-31	₩14.12 Billion ≈ $9.57 Million	₩1.24 Billion ≈ $842.96K	0.088x	-78.91%
2008-12-31	₩17.78 Billion ≈ $12.05 Million	₩7.43 Billion ≈ $5.03 Million	0.418x	+873.55%
2007-12-31	₩17.38 Billion ≈ $11.78 Million	₩745.57 Million ≈ $505.26K	0.043x	--

About Mgenplus Co. Ltd.

KQ:032790 Korea Biotechnology

Market Cap

$20.36 Million

₩30.05 Billion KRW

Market Cap Rank

#24904 Global

#1813 in Korea

Share Price

₩1170.00

Change (1 day)

-3.54%

52-Week Range

₩800.00 - ₩1631.00

All Time High

₩1631.00